anthonyyazdaniml/gliner-biomed-curated-corpus huggingface dataset:
The PAPRICA study aims to test if an intervention directed to General Practitioners (GP) to train them in methods for recommending HPV vaccine with greater confidence and efficiency is effective to increase HPV vaccination coverage in France. As each health professional is associated in France to a specific reference number i.e. "RPPS number", RPPS numbers for all General Practitioners (GP) from the city of Lyon will be randomly allocated either to the intervention arm or to the control arm to ensure that each arm contains 50% of the total number of GPs. After allocation, GPs in the allocation arm will be identified and invited to attend the intervention i.e. a 3-hour workshop at IARC in the presence of HPV vaccination specialists. The effect of the intervention on the HPV vaccination coverage in Lyon will be measured through HPV vaccines reimbursement data extracted from the Inter-Scheme National Information System within the National Health Insurance System (SNIIR-AM : Système National d'Information Inter-Régimes de l'Assurance Maladie ). Linkable data between girls and General Practitioners (GP) via RPPS numbers will allow us to allocate girls either in the intervention or the control arm. Vaccination coverage will be estimated within each of these cohorts.
This paper investigates health impacts at the end of adolescence of prenatal exposure to multiple shocks, by exploiting the unique natural experiment of the Dutch Hunger Winter. At the end of World War II, a famine occurred abruptly in the Western Netherlands (November 1944-May 1945), pushing the previously and subsequently well-nourished Dutch population to the brink of starvation. We link high-quality military recruits data with objective health measurements for the cohorts born in the years surrounding WWII with newly digitised historical records on calories and nutrient composition of the war rations, daily temperature, and warfare deaths. Using difference-in-differences and triple differences research designs, we first show that the cohorts exposed to the Dutch Hunger Winter since early gestation have a higher Body Mass Index and an increased probability of being obese at age 18. We then find that this effect is partly moderated by warfare exposure and a reduction in energy-adjusted protein intake. Lastly, we account for selective mortality using a copula-based approach and newly-digitised data on survival rates, and find evidence of both selection and scarring effects. These results emphasise the complexity of the mechanisms at play in studying the consequences of early conditions.
FIELD: medicine, veterinary science. ^ SUBSTANCE: group of inventions relates to the field of veterinary microbiology. Method for production of vaccine includes extraction of lymphoid cells infected with merocytes Theileria annulata from an animal infected with merocytes Theileria annulata in the form of supernatant from ground mites or in the form of preserved culture, cultivation of infected cells is carried out in growth medium, which represents RPMI 1640 complemented by serum in amount from 10 to 20 % selected from embryonal serum of calf, newborn calf serum or normal bovine serum; solution of antibiotics containing sodium benzylpenicillin 100 ME per ml, sulfate of streptomycin 100 microgram per ml and mycostatin 10 ME per ml; and also 200 mM L-glutamin per ml, at the same time all components are previously sterilised by filtration and purified from any contamination by microorganisms by standard methods. Reproduction of cultivated cells in vitro is done by method of serial passages, at the same time up to 100 passages are carried out with periodicity of two or three times per week, and density of cells inoculation is maintained accordingly as 1ù105 or 2ù105 cells per ml, or by method of their limit dilution in "cupark" trays and growing cloned cultures from one cell by cultures passage up to 200 times in mode of two/three times per week. Cultures are grown up to large volumes to produce vaccine. Vaccine efficiency is tested in wide field conditions on cows Bos Taurus mated with cows Bos Indicusy, and also on newborn calves, less than two months old calves and impregnate cows. Vaccine is safe for all age groups of cattle, including newborn calves and impregnate cows, has high immunogenic activity. ^ EFFECT: development of safe vaccine against theileriosis. ^ 8 cl, 1 tbl, 1 ex
Participants randomized to this group will receive 30 minutes of myofascial massage to their affected breast, chest, and shoulder areas twice a week for 2 months. Therapists will follow a detailed 8 week protocol developed with a massage therapy consultant and the study team.
FIELD: medicine, neurosurgery. SUBSTANCE: after cranial trepanation resolving collagen film is placed between hard brain tunic and head soft tissues instead removed cranium bone. This film comprises dexamethasone in the dose 1-5 mg/sq x cm and lydasa in the dose 16-64 U/sq x cm. Method ensures to enhance effectiveness of treatment due to inhibition of scary tissue maturation. Invention can be used for prophylaxis of rough scar-commissure process between brain tunics. EFFECT: enhanced effectiveness of prophylaxis. 1 ex
There are few effective therapeutic strategies for temporomandibular joint osteoarthritis (TMJOA) due to the unclear pathology and mechanisms. We aimed to confirm the roles of GPX4 and ferroptosis in TMJOA progression. ELISA assay was hired to evaluate concentrations of ferroptosis-related markers. The qRT-PCR assay was hired to assess gene mRNA level. Western blot assay and immunohistochemistry were hired to verify the protein level. CCK-8 assay was hired to detect cell viability. Human fibroblast-like synoviocytes (FLSs) were cultured to confirm the effects of GPX4 and indicated inhibitors, and further verified the effects of GPX4 and ferroptosis inhibitors in TMJOA model rats. Markers of ferroptosis including 8-hidroxy-2-deoxyguanosine (8-OHdG) and iron were notably increased in TMJOA tissues and primary OA-FLSs. However, the activity of the antioxidant system including the glutathione peroxidase activity, glutathione (GSH) contents, and glutathione/oxidized glutathione (GSH/GSSG) ratio was notably inhibited in TMJOA tissues, and the primary OA-FLSs. Furthermore, the glutathione peroxidase 4 (GPX4) expression was down-regulated in TMJOA tissues and primary OA-FLSs. Animal and cell experiments have shown that ferroptosis inhibitors notably inhibited ferroptosis and promoted HLS survival as well as up-regulated GPX4 expression. Also, GPX4 knockdown promoted ferroptosis and GPX4 overexpression inhibited ferroptosis. GPX4 also positively regulated cell survival which was the opposite with ferroptosis. In conclusion, GPX4 and ferroptosis regulated the progression of TMJOA. Targeting ferroptosis might be an effective therapeutic strategy for TMJOA patients in the clinic.
The present invention concerns a polypeptide analog of native keratinocyte growth factor, KGF, with or without signal sequence, wherein the analog comprises the amino acid sequence of KGF comprising a deletion, substitution and/or insertion of one or more of amino acids 1 - 24 whereby the cysteine residue at amino acid position 1 and the cysteine residue at amino acid position 15 each either deleted or substituted with another amino acid optionally further having an N-terminal methionine residue and/or further comprising a charge-change substitution. A pharmaceutical formulation comprising an analog of KGF. A recombinant nucleic acid molecule encoding an analog and a vector comprising a nucleic acid molecule, host cell containing a nucleic acid molecule or a biologically functional vector. A process for the production of an analog of KGF comprising growing a host cell. A use of an analog of KGF for the production of a medicament for stimulating production of non-fibroblast epithelial cells. An in vitro method of stimulating the production of non-fibroblast epithelial cells. Use of an effective amount of deltaN23 for the production of a medicament. A kit comprising an analog of KGF.
With start of the cardiopulmonary bypass conventional therapy with a fixed insulin dosing scheme was initiated. If blood glucose was \> 150 mg/dl, manual insulin therapy was started following a fixed insulin dosing scheme. Measurements of blood glucose were performed during surgery every 30 minutes, and on the ICU every 2 hours until discharge (Routine Care).
Based on findings from animal reproduction studies and its mechanism of action, docetaxel can cause fetal harm when administered to a pregnant woman [see Clinical Pharmacology (12.1)]. Available data from case reports in the literature and pharmacovigilance with docetaxel use in pregnant women are not sufficient to inform the drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. In animal reproduction studies, administration of docetaxel to pregnant rats and rabbits during the period of organogenesis caused embryo-fetal toxicities, including intrauterine mortality, at doses as low as 0.02 and 0.003 times the recommended human dose based on body surface area, respectively.

Advise pregnant women and females of reproductive potential of the potential risk to a fetus. Verify pregnancy status in females of reproductive potential prior to initiating docetaxel. Advise females of reproductive potential to use effective contraception during treatment and for 2 months after the last dose of Docetaxel Injection. Advise male patients with female partners of reproductive potential to use effective contraception during treatment and for 4 months after the last dose of Docetaxel Injection [see Use in Specific Populations (8.1, 8.3)].
A 2016 systematic review that included 30 observational studies (n= 19,813 patients) found high quality evidence that axillary lymph node dissection (ALND) is associated with a 21% absolute risk increase of PPSP (95% CI = 13% to 29%). In many cases of breast cancer, surgery involves axillary approaches; however, preliminary evidence suggests that preservation of the intercostobrachial nerves (ICBN) may reduce the incidence of PPSP after axillary clearance. A 2014 systematic review found 3 small, single-center randomized controlled trials (RCTs), that enrolled a total of 309 patients, and explored the effect of ICBN preservation versus sacrifice during breast cancer surgery. This review found that division of the ICBN was associated with higher risk of sensory deficits, and that nerve preservation techniques increased the median operating time by 5 minutes. Due to limitations of existing evidence, clinical practice guidelines currently provide no recommendations on whether the ICBN should be preserved during axillary lymph node dissection.A large, definitive trial is needed to establish whether nerve preservation techniques are effective in reducing PPSP after breast cancer surgery involving ALND. If all the apparent effect of axillary dissection is associated with lack of ICBN preservation, the absolute reduction of rates of PPSP would be considerable. Furthermore, nerve sparing requires no specialized equipment, suggesting that scalability will be highly feasible.

In addition, there is substantial evidence that neuro-inflammation as a result of neural damage leads to peripheral and central changes that can be described as peripheral and central sensitization, leading to PPSP. As such, we will be conducting a biomarker sub-study as part of the pilot program. Identification of biomarkers to correlate with the development of neuropathic pain may facilitate identification of individuals at risk for development of PPSP at an early stage. The INSPIRE trial provides an important opportunity to compare patients before and after nerve injury to further explore the association of persistent pain with cytokine biomarkers. The findings will improve our mechanistic understanding of PPSP.
Continuous monitoring with ICT-based ECG monitoring will begin from the time of participation in the trial in the ICT-based monitoring group. Depending on the lifestyle pattern of the patient, the specific time will be set to allow 30 min of monitoring per day, even if there are no symptoms. If symptoms do appear, additional monitoring will be performed for at least 10 more minutes. 24-hr Holter monitoring will be implemented at the 3-, 6-, and 12-month follow-ups in this group, as in the Holter monitoring group.
Community nurses play a key role in providing continuous home care for patients with chronic diseases. However, a perfect system of responsibilities and requirements has not yet been formed, and nurses cannot provide high-quality nursing services for home-based patients. We attempted to construct an index of the scope of practice for community nurses providing home-based transitional care for patients with chronic diseases and to guide nurses in playing an active role in transitional care work. From March to May 2023, 14 representative community nurses from the Shanghai Community Health Service Center were selected for group interviews and 2 rounds of Delphi consultation. A total of 14 valid questionnaires were collected. The authority coefficients were 0.94 and 0.93, and the Kendall coefficients were 0.56 and 0.59 for the 2 rounds of expert consultation (P < .05). Finally, an index system, including 6 primary indices (transitional caring provider, patient self-management facilitator, community group intervention organizer, home caregiver supporter, family physician team collaborator and supervisor of home medical equipment use, and medical waste disposal) was constructed for community nurses involved in providing home-based transitional care for patients with chronic diseases. The weight values of the 6 indices were 0.19, 0.17, 0.21, 0.13, 0.14 and 0.16, respectively (CR = 0.035, and the consistency test was passed), and 16 secondary indicators and 42 tertiary indicators were identified. In this Delphi study, an index system that can be used to determine community nurses' roles in providing home-based transitional and continuous care for patients with chronic diseases was successfully established. The index system is considered reliable and easy to use and will provide a meaningful reference for community nurses and policy-makers.
Auditory hallucinations are among the most frequent symptoms in psychotic disorders. While a large group of patients with first episode psychosis achieve remission of psychotic symptoms during first year after initial contact with mental health services, almost one third continue having psychotic symptoms in spite of treatment with antipsychotic medication. Since auditory hallucinations are a major cause of distress and suffering for these patients, there is an essential need to test the effectives of targeted psychotherapeutic interventions in alleviating auditory hallucinations Two previous trials have provided preliminary evidence of the effectiveness of virtual reality therapy on auditory hallucinations, but no trial to date has examined the effect of virtual reality assisted therapy in an adequately powered RCT. In this large-scale randomized, clinical trial, patients in the experimental intervention will be receiving 7 sessions of virtual reality assisted avatar therapy while patients in the control group will receive 7 sessions of supportive contact with mental health care professionals at their regular outpatient clinic.

If the virtual reality therapy is found to be beneficial in reducing the severity of refractory auditory hallucinations, it will be a breakthrough in the current treatment of psychotic disorders. A large group of patients with schizophrenia and related disorders in Denmark and worldwide will be the target group of the therapy. If proven effective, the treatment will be especially relevant for patients with treatment resistant schizophrenia, but the treatment can also be used as an add on to antipsychotic medication for patients with a better prognosis, such as patients with first episode psychosis. If the virtual reality therapy is proven effective, it can be implemented in mental health services in Denmark and internationally. A successful implementation could reduce the costs associated with treatment of schizophrenia.
The Mesulam Cancellation Test is a low cost, quick measure used to screen for hemispatial inattention. The task is also useful for observing a patient's organizational approach. We developed a method to quantify the organizational strategy used by patients in completing this visual scanning task. In this study, we evaluated the reliability of the new method. Participants were 40 patients seen in an outpatient neuropsychology clinic. The 34 men, 5 women, and 1 transitioning individual had a mean age of 49 (SD = 13.94), and mean education of 13.59 years (SD = 2.15). Two raters blinded to patient information provided independent ratings of organization using our new scoring method. Scores ranged from 1 to 5 based on increasing organization. Cohen's weighted Kappa and Spearman's rank order correlation indicated good interrater reliability (Κ(weighted) = .84; rs = .89). The average absolute difference between the raters was .25 (SD = .54). We also found preliminary evidence for the validity of the organizational measure. This study supports the reliability of this new embedded measure of organization. A next step will be to gather normative data, to further establish its validity, and to assess the reliability of the scoring system with other cancellation tests.
Vitamin D (cholecalciferol, 4000 IU) with glucosamine sulfate (1000 mg) and omega-3 fatty acids (eicosapentaenoic (EPA, 580 mg) and docosahexaenoic (DHA, 470 mg) acids). Supplements taken daily for 84 days (12 weeks).
Russian National Health Telephone Survey (RNHTS) is the first public health surveillance study in Russia. The aim of RNTHS is to obtain unique representative data on health-related quality of life, health-related behaviors, and health care utilization indicators for the adult Russian population. Analysis of these indicators provides a detailed outlook on how health is associated with people's well-being, quality of life, and socio-demographic characteristics, which adds to official and aggregated statistics for Russia.

RNHTS consists of five sections. Section 1 includes socio-demographic characteristics of respondents such as their gender, age, marital status, education level, income level, employment status and location. Section 2 measures indicators of general health and health-related quality of life using the 3-level version of the EuroQol-5 Dimension questionnaire (EQ-5D-3L) and the Washington Group Short Set on Functioning questionnaire (WG-SS). Section 3 covers three health-related behaviours of respondents: smoking, drinking alcohol, and physical activity. Section 4 consists of questions about health care utilization in the last 12 months with an emphasis on patient choice between public and private health care. This section also measures how satisfied respondents were with health care services that they used, their unmet needs, and their health care avoidance. Section 5 is modifiable for each round (year) of RNHTS. This version of the protocol describes round 2 of RNHTS. In this round, Section 5 is devoted to measuring prevalence of arthritis in the adult Russian population and how it affects their quality of life as well as to learning about oral health and dental services utilization among Russian adults.

More than 2000 respondents will be randomly selected for RNHTS. All data will be collected using a Computer Assisted Telephone Interview (CATI) system, which allows real-time data capture and consolidation. All interviews will be conducted anonymously. The telephone survey will be conducted by Agency of Social Information St. Petersburg (ASI St. Petersburg). RNHTS data will be analysed using statistical analysis methods which will be presented using summary tables (summary statistics, contingency tables, frequency distributions), correlation coefficients, and estimates of regression models (coefficients, odds ratios, marginal effects). The results of statistical analysis will be compiled in one report with authors' comments on the findings.
Metformin hydrochloride is an oral antihyperglycemic drug used in the management of type 2 diabetes. Metformin hydrochloride (N,N-dimethylimidodicarbonimidic diamide monohydrochloride) is not chemically or pharmacologically related to sulfonylureas, thiazolidinediones, or α-glucosidase inhibitors. It is a white to off-white crystalline compound with a molecular formula of C4H12ClN5 (monohydrochloride) and a molecular weight of 165.63. Metformin hydrochloride is freely soluble in water and is practically insoluble in acetone, ether, and chloroform. The pKa of metformin is 12.4. The pH of a 1% aqueous solution of metformin hydrochloride is 6.68. The structural formula is as shown:

GLUCOVANCE is available for oral administration in tablets containing 1.25 mg glyburide with 250 mg metformin hydrochloride, 2.5 mg glyburide with 500 mg metformin hydrochloride, and 5 mg glyburide with 500 mg metformin hydrochloride. In addition, each tablet contains the following inactive ingredients: microcrystalline cellulose, povidone, croscarmellose sodium, and magnesium stearate. The tablets are film coated, which provides color differentiation.
BACKGROUND: Breast cancer (BC) cases in Makassar, Indonesia, are on the rise, with 2723 cases recorded in 2018. Tumor cells in the blood indicate metastasis, emphasizing the need for early diagnosis and monitoring. Pleiotrophin (PTN) is associated with various human malignancies, and recent studies suggest a correlation between PTN expression and advanced BC stages; therefore, PTN could serve as an independent predictor of metastasis. This study aimed to determine the correlation between serum PTN level, histopathological grading, and metastasis occurrence in BC patients in Makassar, Indonesia.
METHODS: This study used an observational cross-sectional design. Pleiotrophin serum levels were examined using enzyme-linked immunosorbent assays. This study used a t-test and ROC curve analysis for the statistical tests.
RESULTS: Of the 64 samples used in this study, metastasis was present in 26 cases and absent in 38 samples. The mean PTN serum levels in metastatic and non-metastatic breast cancer patients were 4.311 and 1.253, respectively. The PTN receiver operating characteristic curve showed an area under the curve of 2.47 ng/dL, which was statistically significant (p < 0.001). A significant relationship was found between PTN level and metastasis (p < 0.001). The correlation coefficient was 0.791, indicating a positive correlation.
CONCLUSION: This study revealed that the serum PTN level among breast cancer patients had a cut-off value of 2.47 ng/dL. The research established a clear correlation between PTN level and metastasis occurrence in breast cancer patients, indicating a higher likelihood of distant metastasis with elevated PTN concentration.
Will be diagnosed using 'preclinical AD' criteria of mild cognitive impairment supported by a positive biomarker for AD. MCI defined as: 1. History of cognitive decline, noticed by either the patient, family member(s) or a medical practitioner but still independent in most complex daily activities. 2. Documentation of cognition not normal e.g., by MoCA or neuropsychological testing; 3. Does not meet the definition of dementia with MOCA \<18 or global CDR 1 or greater (although exceptions may exist with appropriate justification). 4. Supportive AD biomarker (has positive biomarkers for both Aβ and neuronal injury using CSF or neuroimaging).